BlackRock Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $214M | Sell |
|
|||||
|
2016
Q3 | $280M | Buy |
|
|||||
|
2016
Q2 | $116M | Sell |
|
|||||
|
2016
Q1 | $142M | Sell |
|
|||||
|
2015
Q4 | $252M | Sell |
|
|||||
|
2015
Q3 | $235M | Buy |
|
|||||
|
2015
Q2 | $243M | Buy |
|
|||||
|
2015
Q1 | $202M | Sell |
|
|||||
|
2014
Q4 | $234M | Sell |
|
|||||
|
2014
Q3 | $225M | Sell |
|
|||||
|
2014
Q2 | $220M | Buy |
|
|||||
|
2014
Q1 | $177M | Buy |
|
|||||
|
2013
Q4 | $83.9M | Buy |
|
|||||
|
2013
Q3 | $46.1M | Sell |
|
|||||
|
2013
Q2 | $111M | Buy |
|